BMC Med. 2025 May 28;23(1):314. doi: 10.1186/s12916-025-04035-9.
NO ABSTRACT
PMID:40437496 | DOI:10.1186/s12916-025-04035-9
Categories
Interpreting results from biomarker-guided clinical trials: avoiding “negative” or “failed” terminology
